National Heart, Lung, and Blood Institute; Notice of Proposed Reorganization
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Issuing agencies
Abstract
The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH) will host a public hearing to enable discussion of the Institute's proposal to reorganize the Division of Lung Disease (DLD). The proposed reorganization aims to ensure effective oversight, alignment of expertise, and translation of knowledge within and across research areas in the lung disease field. It establishes a new branch structure that will strategically position leadership over DLD programs, balance workload, and enhance depth/ succession planning for ingrained operational sustainability. There will be no impact on the National Center on Sleep Disorders Research as a result of the restructuring. The online forums will allow members of the public to review the reorganization proposals and submit comments.
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 86 (Thursday, May 4, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 86 (Thursday, May 4, 2023)]
[Notices]
[Page 28570]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-09452]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Proposed
Reorganization
AGENCY: National Institutes of Health, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The National Heart, Lung, and Blood Institute (NHLBI) of the
National Institutes of Health (NIH) will host a public hearing to
enable discussion of the Institute's proposal to reorganize the
Division of Lung Disease (DLD). The proposed reorganization aims to
ensure effective oversight, alignment of expertise, and translation of
knowledge within and across research areas in the lung disease field.
It establishes a new branch structure that will strategically position
leadership over DLD programs, balance workload, and enhance depth/
succession planning for ingrained operational sustainability. There
will be no impact on the National Center on Sleep Disorders Research as
a result of the restructuring. The online forums will allow members of
the public to review the reorganization proposals and submit comments.
DATES: The first public hearing will take place June 6, 2023, at
approximately 11:30 a.m. E.T. during the open session of the National
Heart, Lung, and Blood Institute Advisory Committee meeting. The second
public hearing will take place on June 7, 2023, from 12:00 p.m. to 1:00
p.m. E.T. using the NHLBI DLD Director's Twitter account. Any
interested person may also file written comments by sending an email to
<a href="/cdn-cgi/l/email-protection#127c7a7e707b4d767e76527c7a7e707b3c7f737b7e3c757d64"><span class="__cf_email__" data-cfemail="46282e2a242f19222a2206282e2a242f682b272f2a68212930">[email protected]</span></a> prior to June 7, 2023. The statement should
include the individual's name, and when applicable, professional
affiliation.
ADDRESSES: The following email address may be used for comments on the
reorganization: <a href="/cdn-cgi/l/email-protection#345a5c58565d6b505850745a5c58565d1a59555d581a535b42"><span class="__cf_email__" data-cfemail="bcd2d4d0ded5e3d8d0d8fcd2d4d0ded592d1ddd5d092dbd3ca">[email protected]</span></a>.
The link to the videocast for the first public hearing to occur
during the open session of the NHLBI Advisory Council meeting will be
posted online at: <a href="https://www.nhlbi.nih.gov/about/advisory-and-peer-review-committees/advisory-council">https://www.nhlbi.nih.gov/about/advisory-and-peer-review-committees/advisory-council</a>.
The second public hearing will be held via Twitter using
@NHLBI_LUNGDir.
FOR FURTHER INFORMATION CONTACT: Tony Jackson, Chief of Staff, Division
of Lung Disease, National Heart, Lung, and Blood Institute, National
Institutes of Health, Rockledge Center I, 6705 Rockledge Drive, 4th
Floor, Bethesda 20817, 301-435-0233, <a href="/cdn-cgi/l/email-protection#f39d9b9f919aac979f97b39d9b9f919add9e929a9fdd949c85"><span class="__cf_email__" data-cfemail="d1bfb9bdb3b88eb5bdb591bfb9bdb3b8ffbcb0b8bdffb6bea7">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: The NIH Reform Act of 2006 (42 U.S.C.
281(d)(4)) requires public notice of proposed reorganization plans.
This announcement and the public forum serve as that notice.
Dated: April 27, 2023.
James F. Gude,
Acting Executive Officer, National Heart, Lung and Blood Institute,
National Institutes of Health.
[FR Doc. 2023-09452 Filed 5-3-23; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.